On Day 1 the Main Stage highlights the latest and most impactful advances in sequencing platforms and technologies.

Day 2 focusses on how these advances are accelerating the UK life science ecosystem. It will cover policy updates, how we're improving patient access to novel therapies and maintaining the UK life sciences powerhouse of genomics.

Explore the development of large-scale research datasets, how you can access them and how you can optimise your handling and analysis of data to deliver the best possible outcome in your work.

You will hear about data infrastructure, storage, access, data quality, data diversity and metadata.  

Day 1 features a dedicated NHS Showcase, presenting cutting-edge technologies being translated into clinical practice, through testing services, patient outcomes and integration. 

Day 2 discusses the evolving roles of specialists including genetic counsellors, midwives and nurses from a multi-disciplinary approach.

This theatre focuses on leveraging the full spectrum of cancer omics to better diagnose and clinically profile cancer for better patient outcomes.

It will cover advances in liquid biopsy analysis, molecular profiling and precision oncology.

Explore how the latest single-cell technologies are transforming biological discovery. This theatre highlights the power of single-cell analysis to reveal cellular heterogeneity and integrating multi-modal and spatial data to enhance biological interpretation.

Learn how AI is enhancing analytical precision and how single-cell applications are driving breakthroughs across research and clinical settings.

This theatre covers how to tackle the  integration of diverse omics datasets to better understand biological context.

We will also discuss the advances in AI for multi-omics analysis and how to leverage these for drug discovery.

Uncover how epigenetics and emerging omics are advancing our understanding of gene regulation, disease mechanisms and environmental influences on health.

This theatre covers a diverse array of topics, from cancer epigenetics to neurogenomics, highlighting innovative approaches to tackle biological complexity. 

Dive into the latest developments in cell and gene therapies. From navigating the complexities of implementation to understanding patient impact.

Discuss how advanced therapies are being delivered and scaled in the UK and Europe. 

Unlock the potential of pharmacogenomics to drive smarter, more targeted drug development and clinical decision-making.

Explore how genetic insights are enabling data-driven patient stratification, optimising trial design and supporting the adoption of personalised therapies. 

Discover how AI is reshaping the healthcare data landscape. Dive into AI-driven mining of EHRs, the role of LLMs in interpreting complex clinical and genomic data and how intelligent systems are accelerating clinical trial recruitment and patient matching.

Discover what it takes to build ethical, safe and explainable AI and how these technologies are shifting care models from reactive to proactive.  

Overcome challenges to generate meaningful clinical insights from large proteomics datasets, including single-cell and spatial proteomics, scaling clinical proteomics and advancing precision medicine  using innovative proteomic technologies.  

Explore conditions that affect the female reproductive system, such as ovarian cancer and endometriosis. 

Hear about the latest advancements in children’s health through pre-and-post-natal genomics, newborn screening and paediatric care. 

Investigate patient engagement, inclusive innovation and efforts to support under-represented populations.

On Day 2, the focus shifts to global collaboration, education and the potential of population genomics to improve health outcomes worldwide.